Omeros Corporation (Nasdaq: OMER) today announced two presentations that will be featured at the 2025 Tandem Meetings – the ...
Researchers discovered a previously unknown mechanism that may drive tissue damage and a new target for drug discovery.
6d
News Medical on MSNResearchers discover a major driver of inflammatory pathology in autoimmune and chronic inflammatory diseasesOur immune system is armed with an array of defenses designed to detect and eliminate harmful threats. One of its most powerful defense mechanisms is the complement system—a group of proteins that ...
Objective Combination therapy with rituximab and belimumab is a novel treatment strategy for severe SLE and lupus nephritis.
One long insect PGRP, PGRP-LC, is a transmembrane receptor that recognizes diaminopimelic acid-containing peptidoglycan and activates the IMD signal transduction pathway. Both the Toll and IMD ...
Recipient T cells recognize donor antigens via two distinct pathways: the direct pathway (intact donor MHC ... and via direct complement-dependent, antibody-mediated cytotoxicity.
After hours: February 7 at 7:44:24 PM EST Loading Chart for OMER ...
Day of Atonement; the scapegoat; the eating of blood forbidden; civil and religious laws; immorality forbidden We should also forgive and choose not to remember offenses against ourselves or others.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results